Your browser doesn't support javascript.
loading
Isolation, purification and identification of two new alkaloids metabolites from marine-derived Verrucosispora sp. FIM06025.
Chen, Ming-Hong; Zhang, Wen-Long; Chen, Li; Lin, Ru; Xie, Yang; Fang, Dong-Sheng; Lian, Yun-Yang; Jiang, Hong.
Affiliation
  • Chen MH; a Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology , Fuzhou , People's Republic of China.
  • Zhang WL; a Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology , Fuzhou , People's Republic of China.
  • Chen L; a Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology , Fuzhou , People's Republic of China.
  • Lin R; a Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology , Fuzhou , People's Republic of China.
  • Xie Y; a Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology , Fuzhou , People's Republic of China.
  • Fang DS; a Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology , Fuzhou , People's Republic of China.
  • Lian YY; a Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology , Fuzhou , People's Republic of China.
  • Jiang H; a Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology , Fuzhou , People's Republic of China.
Nat Prod Res ; 33(20): 2897-2903, 2019 Oct.
Article in En | MEDLINE | ID: mdl-30445864
ABSTRACT
Chemical investigation of a marine-derived actinomycete strain Verrucosispora sp. FIM06025 isolated from a marine sponge sample collected from the East China Sea, resulted in the discovery of two new alkaloids, (2-(hydroxymethyl)-3-(2-(hydroxymethyl)-3-methylaziridin-1-yl) (2-hydroxyphenyl) methanone (1) and 2-(1-hydroxyethyl)-3,4-dihydrobenzo [f] [1,4]oxazepin-5(2H)-one (2). The structures of compounds 1 and 2 were determined by the detailed analysis of 1D, 2D NMR and HR-TOF-MS data, along with literature data analysis. The bioefficacy investigations revealed that compound 1 exhibited a broad spectrum of antimicrobial activity with MIC (minimum inhibitory concentration) values ranging from 3.4 to 200 µg·mL-1 against H. pylori, P. aeroginosa, A. baumanniiin, E. coli and K. pneumonia, S. aureus, C. albicans and E. faecium, however, compound 2, up to 200 µg/mL, displayed no antibacterial activity against these bacteria.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Actinobacteria / Alkaloids / Anti-Infective Agents Type of study: Diagnostic_studies Limits: Animals Country/Region as subject: Asia Language: En Journal: Nat Prod Res Year: 2019 Document type: Article Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Actinobacteria / Alkaloids / Anti-Infective Agents Type of study: Diagnostic_studies Limits: Animals Country/Region as subject: Asia Language: En Journal: Nat Prod Res Year: 2019 Document type: Article Publication country: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM